You searched for "retinopathy"
Passing the Refraction Certificate as a Foundation doctor
Application for ophthalmic specialist training (OST) is competitive. This means you should consider making every effort to maximise your portfolio points, as it may have a significant contribution to your OST application ranking. The “Commitment to Specialty” section is the...BARS (British Association of Retinal Screening) Conference 2023
Why not join us at the BARS Conference 2023 in the vibrant city of Bristol, at the Marriott Hotel on Thursday 28 and Friday 29 September. This year there is something for everyone with an interest in diabetic eye screening....
Changing surgery trends from 2009–2020
This paper reports a review of the number and type of surgeries over one decade in a Portuguese hospital. This was a retrospective review of 2050 surgeries. About 70% were strabismus surgery and the remainder included anterior segment and retinopathy...In conversation with Dr Hazel Shillingford-Ricketts
We spoke to Dr Hazel Shillingford-Ricketts about the work of Vision 2020 LINKS and treatments in diabetic retinopathy.
Detecting apoptosis in retinal cells
This is a review paper in which the authors summarise the transitioning of techniques detecting apoptosis from bench to bedside, along with the future possibilities they encase. Detection of Apoptosis in Retinal Cells (DARC) technology can be used as a...Development of eyecare services in Dominica: Past, present, and future
Dominica is a small island developing state in the Caribbean with a population of approximately 73,000 people [1] and has a long and proud history of developing eyecare services through international partnerships. This article will give you an outline of...
Adjuvant radiotherapy in orbital malignancy
This is a retrospective review of high dose volumetric modulated arc radiotherapy (VMAT) for adjuvant treatment of patients with orbital malignancy who had already undergone local excision or exenteration. VMAT differs from conventional external beam radiotherapy in that it is...
IAC vs. IVC chemotherapy for RB
This a single centre retrospective review of consecutive patients between 1997 and 2014, of all sporadic unilateral retinoblastoma (RB) group D cases, treated with combined intravenous chemotherapy (IVC) and focal treatments (1997- 2008), or intra-arterial chemotherapy (IAC) treatment (2008 to...
Aflibercept, bevacizumab or ranibizumab for diabetic macular oedema
Macular oedema (MO) is a leading cause of visual impairment in patients with diabetic retinopathy. Whilst laser photocoagulation therapy has been the proven treatment for decades, studies over the last five years have also established a role for anti-VEGF agents...
Intensive diabetes therapy and ocular surgery in type 1 diabetes
The Diabetes Control and Complications Trial (DCCT) ran between 1983 and 1993 and showed that intensive glycaemic control was beneficial in reducing diabetic retinopathy in type 1 patients. There was a 76% reduction in onset of retinopathy and a 52%...
